openPR Logo
Press release

Author's Tranquility Press Presents Marcia Kosar's Debut Novel, 'Innocence on the Move...Not the Road Trip you took with your Parents!'

04-13-2024 12:08 AM CET | Associations & Organizations

Press release from: ABNewswire

Author's Tranquility Press Presents Marcia Kosar's Debut

Travel enthusiast Marcia Kosar released her debut work of fiction, 'INNOCENCE ON THE MOVE [https://www.amazon.com/Innocence-Move-Marcia-Kosar/dp/1961123835/]' on [Friday, March 24, 2024]. Inspired by the true events in Kosar's life, this entertaining novel follows the journey of two-spirited young women, Marcia and Zoe, who embark on an amazing cross-country road trip to the West Coast in August 1971.

Whether the reader is a BOOMER or a 20-year-old ZOOMER they will be surprised by the unique, often unexpected, and sometimes-sensational situations the girls stumble into! And, they will witness how an adventure can go from exhilarating to terrifying in a split second and will discover how a night can turn magical, mystical or described as magnificent!

Marcia Kosar, a gifted storyteller, masterfully weaves throughout the book a glance into America's music scene from the "Motor City" to L.A. and a peek into lives of the people they meet along the way.

Kosar hopes her novel inspires others to travel the world and witness all that it has to offer. "If you have been dreaming of a road trip, my wish is that you are now inspired to take action," she says. "Should your budget be extremely tight, you might start small by just visiting a new park, library or coffee shop. It's time to shake things up!"

"Innocence on the Move" is now available on Amazon [https://www.amazon.com/Innocence-Move-Marcia-Kosar/dp/1961123835/].

About the Author

Marcia Kosar is a seasoned real estate professional and public speaker, showcasing her expertise at national conventions and in Realtor trade magazines. As a lifelong adventurist, she has explored over 70 countries and currently partakes in outdoor adventures with the women's empowerment group "Sisters on the Fly". A native of the Detroit area, Kosar has lived with her husband at the base of "The Flatirons" in Boulder, Colorado, since 1978.

About Author's Tranquility Press

Author's Tranquility Press is a full-service publishing company that helps authors of all levels bring their books to life. They offer a wide range of services, including editing, proofreading, cover design, marketing, and distribution. They are committed to helping authors achieve their publishing goals, working closely with them every step of the way.

Media Contact
Company Name: Author's Tranquility Press
Contact Person: Louela Sanders, Fulfillment Associate - Marketing
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=authors-tranquility-press-presents-marcia-kosars-debut-novel-innocence-on-the-movenot-the-road-trip-you-took-with-your-parents]
Phone: 8664118655
Address:3900 N Commerce Dr. Suite 300 #1255
City: Atlanta
State: GA, 30344
Country: United States
Website: http://www.authorstranquilitypress.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Author's Tranquility Press Presents Marcia Kosar's Debut Novel, 'Innocence on the Move...Not the Road Trip you took with your Parents!' here

News-ID: 3462541 • Views:

More Releases from ABNewswire

Dee Agarwal on the right KPIs to be thinking about for optimal ROI
Dee Agarwal on the right KPIs to be thinking about for optimal ROI
Dee Agarwal emphasizes the importance of selecting the right KPIs to optimize ROI, advocating for metrics that directly impact business health. He also stresses that while data is crucial, businesses should not overlook the human element, encouraging investment in team skills, agility in strategy, and a long-term focus on sustainable growth and customer loyalty. ATLANTA, GA - MAY 31, 2024 - In the ever-evolving world of business strategy, a laser focus
PD-1 and PD-L1 Inhibitors Market is expected to sour at a decent CAGR by 2020-2034, eatimates DelveInsight | Isunakinra, Dato-DXd, ONC-392, ZYNYZ (retifanlimab), Spartalizumab (PDR001), more
PD-1 and PD-L1 Inhibitors Market is expected to sour at a decent CAGR by 2020-20 …
PD-1 and PD-L1 inhibitor companies are Buzzard Pharmaceuticals, AstraZeneca, Daiichi Sankyo, Inc., OncoC4, Inc., BioNTech SE, Incyte, MacroGenics, Novartis, GlaxoSmithKline, Phanes Therapeutics, Compass Therapeutics, HUYABIO International, LLC., Bristol-Myers Squibb, Chugai Pharma USA, Bayer, Istari Oncology, Calico Life Sciences, AbbVie, NeoImmuneTech, Kartos Therapeutics, Inc., CellSight Technologies, Inc., Glenmark Specialty S.A., Jounce Therapeutics, Inc., Turnstone Biologics, and others. (Albany, USA) DelveInsight's PD-1 and PD-L1 Inhibitors Market Insights report includes a comprehensive understanding of
HDAC Inhibitor Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration, companies by DelveInsight | Givinostat, ACS 33, MG 4915, more
HDAC Inhibitor Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, HDAC Inhibitor pipeline constitutes 50+ key companies continuously working towards developing 50+ HDAC Inhibitor treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "HDAC Inhibitor Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the HDAC Inhibitor Market. The HDAC Inhibitor Pipeline report embraces
TROP-2 Inhibitors Market to Grow at a decent CAGR during the Study Period (2020-2034) by DelveInsight | Datopotamab deruxtecan, MK-2870/SKB-264, DB-1305/BNT325, and BIO-106
TROP-2 Inhibitors Market to Grow at a decent CAGR during the Study Period (2020- …
TROP-2 inhibitor companies are Daiichi Sankyo, AstraZeneca, Kelun Biotech, Merck, DualityBio, BioNTech, BiOneCure Therapeutics, and others. (Albany, USA) DelveInsight's TROP-2 Inhibitors Market Insights report includes a comprehensive understanding of current treatment practices, emerging TROP-2 inhibitors, market share of individual therapies, and current and forecasted TROP-2 inhibitors market size from 2020 to 2034, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan]. Key Takeaways

All 5 Releases